Effects of a motor-cognitive stepping exergame training in older adults

ISRCTN ISRCTN14855620
DOI https://doi.org/10.1186/ISRCTN14855620
Submission date
06/06/2019
Registration date
12/06/2019
Last edited
07/10/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Falls are a major problem in older adults. Maintaining balance during walking is not merely a motor task but also a cognitive task that involves attention, planning of a movement or constraining from it. To improve these aspects of postural control in older adults, researchers have developed a specific computer-based training program that combines specific stepping exercises with motivating gaming elements. The aim of this study is to determine whether this game-based exercise program is effective for improving stepping function in independently living older adults with moderate functional limitations.

Who can participate?
Community-dwelling adults over 60 years of age able to walk independently with or without a walking aid

What does the study involve?
Participants are randomly allocated to one of two groups (intervention group or control group). Both groups engage in weekly balance and strength exercises. During a ten-week period, individuals in the intervention group weekly receive exergame training aiming to improve stepping function. All participants complete an exergame assessment at the beginning of the study, at the end of the training period and ten weeks after the end of the training period.

What are the possible benefits and risks of participating?
Participants may benefit from improved dynamic postural control. Participating in the study is not associated with any specific risks.

Where is the study run from?
AGAPLESION Bethanien Hospital / Geriatric Centre of Heidelberg University (Germany)

When is the study starting and how long is it expected to run for?
March 2015 to January 2016

Who is funding the study?
AGAPLESION Bethanien Hospital / Geriatric Centre of Heidelberg University (Germany)

Who is the main contact?
Prof. Dr. Klaus Hauer
khauer@bethanien-heidelberg.de

Contact information

Prof Klaus Hauer
Scientific

Rohrbacher Straße 149
Heidelberg
69126
Germany

ORCiD logoORCID ID 0000-0001-8041-5705
Phone +49 (0)6221 3191532
Email khauer@bethanien-heidelberg.de

Study information

Study designSingle-center randomized controlled intervention trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typePrevention
Participant information sheet Not available in web format. Please use the contact details to request a patient information sheet
Scientific titleEffects of a motor-cognitive stepping exergame training in older adults: a randomized controlled trial
Study hypothesis1. 10-week individual supervised exergame training improves dynamic postural control as assessed by specific internal exergame outcome parameters.
2. Effects of training on dynamic postural control as assessed by the specific exergame outcome parameters are sustained after the end of the intervention at 10-week follow-up.
Ethics approval(s)Approved 26/05/2015, Ethics Committee I of the Medical Faculty of Heidelberg University (Alte Glockengießerei 11/1, 69115 Heidelberg, Germany, Tel: +49 (0)6221 562646-0; Email: ethikkommission-I@med.uni-heidelberg.de), ref: S-242/2015
ConditionGeriatric related conditions
InterventionEligible participants are randomly assigned to the intervention or control group. Both groups engage in weekly strength and balance exercises. In the course of the trial individuals in the intervention group additionally receive a 10-session individual supervised exergame training with one session of 20 minutes per week.

The exergame intervention addresses the complex motor-cognitive demands of stepping. The exergame is performed on an interactive training device (Impact Dance Platform, Positive Gaming BV, BZ Haarlem, Netherlands) – a pressure sensitive plate connected by a USB port to a desktop computer and a screen and running with a game software created by Dividat® (Dividat AG, Schindellegi, Switzerland). Participants’ step position and timing information of the stepping moment are tracked by contact sensors located within four pressure sensitive areas, each area marked with an arrow corresponding to the direction of the step. To play the game, participants are standing on the central section of the platform, feet closely parallel. Steps are cued by the squares, randomly moving from the central position to one of the four static squares. When executing the indicated steps, participants have to meet the point in time when a moving square is superimposed on a static one. The game includes ten levels, each of one-minute duration, split into two sub-sessions. In sub-session one progressive difficulty is achieved by increasing task speed, as well as by step directions involved in the level. Sub-session two additionally includes a randomly-presented task targeting inhibitory control: Participants have to restrain reaction when instead of a moving square a triangle appeared, and to react also to moving triangles if static squares switched to triangles. Completion criterion for both sub-sessions is set at minimum 50 percent of successfully executed actions within the level. If the criterion is met, the participant moves to the next level.
Intervention typeDevice
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)
Primary outcome measureInternal game parameters (reaction time [msec], game scores [scores]) measured using tailored assessment strategy at baseline (T1), after the intervention period (T2) and at 10-weeks’ follow-up (T3)
Secondary outcome measuresIntervention adherence measured as percent attended sessions
Overall study start date05/03/2015
Overall study end date18/01/2016

Eligibility

Participant type(s)Healthy volunteer
Age groupSenior
SexBoth
Target number of participants54
Total final enrolment58
Participant inclusion criteria1. Aged 60 years or older
2. Cognitively intact, Mini-Mental State Examination (MMSE) score ≥ 24
3. Ability to walk independently with or without walking aid
4. Written informed consent
5. Adequate language level
Participant exclusion criteriaUncontrolled or terminal neurologic, cardiovascular, metabolic or psychiatric disorder
Recruitment start date01/06/2015
Recruitment end date30/06/2015

Locations

Countries of recruitment

  • Germany

Study participating centre

AGAPLESION Bethanien Hospital /Geriatric Centre at the Heidelberg University
Rohrbacher Straße 149
Heidelberg
69126
Germany

Sponsor information

AGAPLESION Bethanien Hospital / Geriatric Centre of Heidelberg University
Hospital/treatment centre

c/o Prof. Dr. Klaus Hauer
Rohrbacher Straße 149
Heidelberg
69126
Germany

Phone +49 (0)6221 3191532
Email khauer@bethanien-heidelberg.de
ROR logo "ROR" https://ror.org/040z4nv21

Funders

Funder type

Hospital/treatment centre

AGAPLESION Bethanien Hospital / Geriatric Centre of Heidelberg University

No information available

Results and Publications

Intention to publish date01/07/2019
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPublication of study results is planned.
IPD sharing planAs the study was not publicly funded, open access of the data was not planned and was therefore also not included in the study protocol. Consequently, it was also not a part of the ethical vote. Independent from open public data access, all scientific data in the research department is continuously open for potential formal external study evaluation. At the participant level, individual feedback concerning training results was provided for each participant as a benefit for study participation.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 29/09/2020 07/10/2020 Yes No

Editorial Notes

07/10/2020: Publication reference and total final enrolment number added.
11/06/2019: Trial's existence confirmed by ethics committee.